Skip to main content

Cancer Australia Guidelines

Home>Publications & Resources>Clinical Practice Guidelines>
A A

Cancer Australia Guidelines

The following is a list of Clinical Practice Guidelines and guidance materials that have been produced by Cancer Australia.

Displaying 1 - 20 of 22
Guideline Title Topic Revision Date
Management of menopausal symptoms in women with a history of breast cancer Early breast cancer
Clinical guidance for the management of lobular carcinoma in situ Early breast cancer
Hypofractionated radiotherapy for early (operable) breast cancer Early breast cancer
Clinical guidance for responding to suffering in adults with cancer Psychosocial care
First-line chemotherapy for the treatment of women with epithelial ovarian cancer Ovarian cancer
CNS metastases in women with secondary breast cancer Advanced Breast Cancer
Recommendations for the management of early breast cancer in women with an identified BRCA1 or BRCA2 gene mutation or at high risk of a gene mutation Early breast cancer
Follow up of women with epithelial ovarian cancer Ovarian cancer
Recommendations for the identification and management of fear of cancer recurrence in adult cancer survivors Psychosocial care
Recommendations for use of bisphosphonates in early breast cancer Early breast cancer
Recommendations for use of hypofractionated radiotherapy in early (operable) breast cancer Early breast cancer
Recommendations for staging and managing the axilla in early (operable) breast cancer Early breast cancer
Recommendations for the management of women at high risk of ovarian cancer Ovarian cancer
Recommendations for use of bisphosphonates for advanced breast cancer Advanced Breast Cancer
Recommendations for use of chemotherapy for the treatment of advanced breast cancer Advanced Breast Cancer
Recommendations for follow-up of women with early breast cancer Early breast cancer
Recommendations for use of Sentinel node biopsy in early (operable) breast cancer Early breast cancer
Recommendations for use of endocrine therapy for the treatment of hormone receptor-positive advanced breast cancer Advanced Breast Cancer
Recommendations for use of Taxane-containing chemotherapy regimens for the treatment of early (operable) breast cancer Early breast cancer
Recommendations for use of Trastuzumab (Herceptin®) for the treatment of HER2-positive breast cancer Advanced Breast Cancer

Pages